|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
.
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
Bugamed Biyoteknoloji Sanayi ve Ticaret A.Ş., in which our subsidiary Alesta Elektronik Teknoloji Yatırım A.Ş. participated by 2.5% on 30.10.2020 with a company valuation of TL 10.000.000, this time received a new investment with a company valuation of TL 100.000.000. Alesta maintained its existing stake in the investment round.
BUGAMED, which increased its company valuation by 900% in less than 3 years, plans to produce medical collagen from organic wastes using high technology. Medical collagen, which we are dependent on imports because it is not produced in our country, is used as raw material in the production of artificial heart valves, artificial cornea, artificial skin and many medicines.
We kindly present it to the information of our shareholders.
|
||||||||